Effect of a gel containing pilocarpine on vaginal atrophy in castrated rats. [PDF]
Clinics (Sao Paulo), 2016 de Sousa-Lages CA +11 more
europepmc +2 more sources
Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy [PDF]
International Journal of Women's Health, 2016 Santiago Palacios,1 María Jesús Cancelo2 1Palacios Institute of Women’s Health, Madrid, Spain; 2Gynecology and Obstetrics Department, Guadalajara University Hospital, University of Alcalá, Spain Abstract: The physiological ...
Palacios S, Cancelo MJ
doaj +2 more sources
Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies. [PDF]
Drugs Context, 2020 Blanco ZE, Lilue M, Palacios S.
europepmc +3 more sources
The effect of vaginal cream containing herbal extracts (Foeniculum vulgare, Salvia officinalis and Flaxseed) on the mental symptoms of vaginal atrophy in postmenopausal women: A randomized controlled clinical trial [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021 Introduction: Most menopausal women experience changes due to decreased estrogen secretion. Vaginal atrophy is one of the most common changes during menopause.
Golshan Tahmasebi +4 more
doaj +1 more source
EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy [PDF]
Maturitas, 2012 Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the clinical use of vaginal estrogens for this condition focussing on publications since the 2006 Cochrane systematic review. Use after breast cancer, before assessment of cervical cytology and prolapse surgery is also discussed.
Margaret Rees +9 more
openalex +5 more sources
The Concept behind the Suitability of Menstrual Blood-Derived Stem Cells for the Management of Vaginal Atrophy among BRCA Mutation Carriers after RRSO. [PDF]
Int J Mol SciCordeiro MR +2 more
europepmc +3 more sources
Epithelial thinning in vaginal atrophy related to lowering of calcitonin gene-related protein, vascular endothelial growth factor, and nerve growth factor expressions in a menopausal rat model [PDF]
Journal of Pharmacy & Pharmacognosy Research, 2023 Context: Vaginal atrophy has been observed as a common sexual problem in post-menopausal women. The targeted protein to counteract menopause problems related to vaginal epithelial thinning is currently a research problem that has not been fully ...
An Nisa Fithri +4 more
doaj +1 more source
The effect of herbal medicines on vaginal atrophy in postmenopausal women: A systematic review and meta-analysis [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2022 Introduction: Vaginal atrophy is one of the relatively common problems in menopausal ages and a major health concern in this group of women. Several studies have been done in the field of herbal medicine in this subject, but different findings have been ...
Mahla Salarfard +3 more
doaj +1 more source
Evaluation of the effect of Chamomile vaginal gel on Subjective symptoms of vaginal atrophy in postmenopausal women: A randomized clinical controlled trial [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019 Introduction: Vaginal atrophy is caused by estrogen deficiency in postmenopausal women and affects their quality of life. The present paper aimed to investigate the effects of chamomile vaginal gel on the subjective symptoms of vaginal atrophy in ...
Zahra Bosak +4 more
doaj +1 more source
Effect of Glycyrrhiza glabra vaginal cream on the mental symptoms of vaginal atrophy in postmenopausal women [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2018 Introduction: Vaginal atrophy is one of the most common postmenopausal symptoms affecting the quality of life among postmenopausal women. Although the use of estrogen is effective in the improvement of these symptoms, it is associated with various ...
Mastaneh Sadeghi +3 more
doaj +1 more source